Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition

Overview of attention for article published in Investigational New Drugs, October 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 66 followers.

#BreastCancerAwareness #breastcancer #gastricancer #cancers #Cancer #her2 New epitiope target for Her2 https://t.co/TvytH9jbqQ

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.